Vigmed now expects first deliveries of CLiP®Ven and CLiP®Neo during first quarter 2014

Vigmed has previously indicated to the market that the first sales of the product CliP Ven were to be expected during the fourth quarter of 2013, and CliP Neo during the first quarter 2014.  During the installation of the production equipment it has become evident that certain minor adjustments are needed to be made to one of the production tools, with the consequence that the first deliveries of CliP Ven to customers will be slightly delayed until the first quarter of 2014. No delays are expected for CliP Neo

Vigmed CLiP is a unique needle protection device for IV catheters which is self-activating during the insertion process, and automatically protects the patient, as well as staff, against accidental and potentially contaminated needlesticks.  CLiP is one of the product categories within a range of products developed by Vigmed.  These products are user friendly and safe, as well as offering a cost effective solution for healthcare systems.  The response to Vigmed’s products from users and distributors both within and outside of Europe has been extremely positive and expectations are high for the coming market introduction.

For further information contact:
Chairman of the Board Lennart Holm (+46 70-630 8562) or CEO Finn Ketler (+46 42 600 5311).

Please feel free to visit the company’s new website at www.vigmed.com

Vigmed is a Swedish medical technology company whose mission is to eliminate needlestick injuries by offering the market unique needle-protected products. Vigmed is headquartered in Helsingborg, Sweden, and has approximately 15 employees. Vigmed’s share is traded on NASDAQ OMX First North in Stockholm (ticker VIG) and has approximately 5 400 shareholders. Remium Nordic AB is the Company’s Certified Advisor. Additional information such as company description, a video presentation and risk factors can be found on Vigmed’s website: www.vigmed.com/investor

Tags: